Opinion
The “singularity” is a term favored by futurists like Google exec Ray Kurzweill, typically in reference to computer technology.
A look at the FDA’s long-awaited guidelines on how it will regulate regenerative medicine products, including stem cells.
Sage Therapeutics has been on a roll with good news lately.
The drug developed by Alkermes took a lot of flack but proved effective in a recent study.
We write about science every day, why isn’t it getting through to the public consciousness?
Big pharmas are having a good year so far in terms of FDA approvals.
Incyte has been at the forefront of the IDO race with its candidate epacadostat.
Rumor is there’s a new approach to fighting cancer in town.